Dr. Arpeet Shah

Dr. Arpeet Shah
Dr. Shah brings a wealth of leading-edge knowledge and experience to his compassionate care. He is a prolific and expert researcher, writer and presenter on a variety of urological and related topics, including urological obstructions and stenting, the effect of opioid dependence, tumors and infection. Dr. Shah speaks many different languages, including English, Gujurati, Hindi and Spanish, and was an International volunteer with Unite for Sight Global Impact Fellow. He has also served as a Research Assistant, University of Illinois at Chicago/Pierce Biotechnology. Dr. Shah served on the Development of Urban Health Outreach Program with the University of Illinois at Chicago Urban Medicine Program. Dr. Shah currently is a member of the University of Chicago Ingalls Memorial Hospital Executive Surgical Committee, Advocate South Suburban Surgical Peer Review Committee, University of Chicago Ingalls Memorial Hospital Surgical Executive Committee and Advocate Physician Partners QURE Urology Quality Project Developer. When he's not in the office, Dr. Shah enjoys playing golf, listening to music and concerts, as well as playing drums and piano. He also likes to travel and bikes.

Languages Spoken:

English

Medical School:

University of Illinois at Chicago College of Medicine

Residency:

Loyola University Medical Center - Chief Resident, Urology

Fellowship:

Loyola University Medical Center, in Endourology and Minimally Invasive Surgery

Undergraduate:

University of Illinois at Chicago

Locations

Associated Urological Specialists Homewood, IL

17901 Governors Hwy, Suite 202Homewood, Illinois, 60430United States
708-957-0220 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only